Skip to content

De bescherming van salbutamol tegen inspiratoire luchtwegobstructie ten gevolge van inspanning bij astmatische kinderen

The protective effect of a single dose salbutamol against exercise induced inspiratory airflow obstruction in asthmatic children

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON24513
Enrollment
15
Registered
2013-06-04
Start date
2013-09-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exercise induced asthma/ inspanningsastma. Inspiratory airflow obstruction/ inspiratoire luchtwegobstructie.

Interventions

Two exercise challenge test (older children perform this test on a treadmill, younger children on a jumping castle). 15 minutes prior to the test children inhale either 200ugr salbutamol or a placebo.

Sponsors

Medische Spectrum Twenten
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Clinical history of EIB. - Age 8 till 16 years old. - Ability to jump or run and perform reproducible lung function tests, i.e. coefficient of the predicted value variation in 3 of 5 consecutive measurements < 5%.

Exclusion criteria

Exclusion criteria: - Exacerbation in the last 4 weeks prior to the ECT (hospital admission or use of systemic corticosteroids). - Use of long acting bronchodilators 24 hours before testing. - Use of short acting bronchodilators 8 hours before testing. - Use of leukotriene antagonists 24 hours before testing. - Other pulmonary or cardiac disorder.

Design outcomes

Primary

MeasureTime frame
The protective effect of a single regular dose of salbutamol compared with a placebo against inspiratory airflow obstruction in asthmatic children aged 8 till 16 years old.

Secondary

MeasureTime frame
The relation between the protective effect of salbutamol against inspiratory airflow obstruction and EIB.

Contacts

Public ContactR. Visser

Medisch Spectrum Twente Departement of pediatrics Haaksbergerstraat 55

R.Visser@mst.nl+31 (0)53 4872310

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)